Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: yosi s who wrote (1100)	7/29/1998 8:08:00 AM
From: Ariella	Read Replies (2) of 1491

From GLOBES today: <<Last week, I wrote that the Castle Creek hedge fund is exerting pressure on the Pharmos share, since it has an interest in seeing the share fall in the short termOn the basis of the share's performance in the past two weeks, it is worth the hedge fund's while to start converting its preferred stock. I estimate that Castle Creek will either cease pressure on the share this week, or will try to force another round of falls (in which case the pressure will disappear within two to three weeks). Castle Creek, which wishes to convert its preferred stock to shares at the lowest possible price, should beware it does not miss the train. Pharmos is expected to publish very important in October (trials of the HU211 drug), and new momentum players are expected to buy into the share even beforehand. Should Castle Creek not convert its holdings to shares by September, the share is liable to start climbing, and the window of opportunity will vanish. I therefore expect this "nuisance" to disappear in the very near future.>> globes.co.il

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next